SXC Health Solutions Corp. (NASDAQ:SXCI) rose over 2% thanks to positive note from Credit Suisse. The firm maintained its investment rating on the stock and says the next major catalyst for the company …
Archive for July, 2012
Apple: WSJ Jumps On the iPad Mini Rumor Mill
Well, now that settles it. The Wall Street Journal this morning jumped into the Apple iPad Mini rumor-mongering game, asserting that component suppliers in Asia are getting ready "for mass production" in September of a tablet computer with a screen of less than 8 inches, smaller than the current 9.7-inch screen. [...]
Obagi: Over-Hyped Aquisition Target Or Worthy Investment?
By Scott Matusow, ContributorThere has been abundant buzz on a company whose shares have been rising steadily since February. Obagi Medical Products (NASDAQ:OMPI) saw shares hit $16.03 last week as speculators …
Three ETF Strategies That Worked (And Two That Didn’t)
Last Friday saw an encouraging end to what had been an extremely disappointing quarter, with stocks surging globally amidst at least temporary optimism over the outlook for Europe. But the one-day rally …
Pharmacyclics Outperformed Other Biotechs In June With A 74% Gain
June was a great month for health stocks – and biotechs in particular – with seven stocks gaining more than 40% over the month. The biggest winner was Pharmacyclics, which rose 74% on the prospects for its ibrutinib treatment for chronic lymphocytic leukemia. According to Needham analyst Alan Carr, CLL patients [...]
This Week In ETFs: July 1st Edition
After a week full of both economic and political happenings, stocks rallied in their second-largest jump of the year. These gains can be directly attributed to efforts that took place at the two-day euro …

